 |
인쇄하기
취소
|
KFDA moves to monitor safety of marketed drugs
Published: 2009-02-02 06:59:00
Updated: 2009-02-02 06:59:00
The Korea Food and Drug Administration said it has been implementing its on-spot inspection on marketed drugs to ensure the ongoing safety of marketed medicines.
The health watchdog said that it will look into the safe profile of 80 drugs with no or less reporting of adverse events.
“Our postmarketing surveillance (PMS) will be accomplished by reassessing drug risks based on new data lear...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.